ArticleInternational ophthalmology2025
Investigation of topographic, aberrometric, and endothelial cell features of the cornea in Fabry disease.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigated topographic, aberrometric, and endothelial cell characteristics of the cornea in Fabry disease and compared them to healthy eyes.
methodsThis prospective, cross-sectional study included 21 patients with Fabry disease and 41 healthy volunteers in Fabry disease (FG) and control (CG) groups, respectively. After ophthalmological examinations, the topographic, tomographic, and aberrometric corneal data were acquired using a Scheimpflug-Placido disk system anterior segment analysis device. The corneal endothelial examination was conducted using a specular microscopy device, and results were compared. A p-values of < 0.05 were considered statistically significant.
resultsNo significant differences were noted between the age and gender of the groups (p > 0.05). Central and thinnest corneal thickness were significantly lower in the FG than in the CG (p = 0.036 and 0.023, respectively). Although the aberrometric values of the cornea were usually higher in the FG, this difference was not significant. No significant differences were observed between the two groups regarding corneal endothelial data examined by specular microscopy. When the eye data with cornea verticillata in the FG were compared with those of the CG, anterior higher-order aberrations (HOA) were significantly higher in the FG (p = 0.047) than in the CG.
conclusionsCornea verticillata associated with Fabry disease can increase HOA in the eye.
Indexed as
Identifiers
40319144What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.